TP53 and esophageal squamous cell carcinoma: Together, these results suggest that the amplification and overexpression of TP63 due to TP53 loss of function causes elevated EFNB1-EPHB4 interaction among epithelial cells, which promotes ESCC progression via accelerated cell cycle and EMT.